Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

triLift By Lumenis Receives Medical Device License from Health Canada, Launches in Canada
  • Israel - English


News provided by

Lumenis Be Ltd.

Mar 25, 2024, 08:00 ET

Share this article

Share toX

Share this article

Share toX

triLift, facial muscle stimulation technology, addresses key signs of facial aging using Dynamic Muscle Stimulation technology (DMSt™), for a naturally lifted look.

SAN JOSE, Calif., March 25, 2024 /PRNewswire/ -- Lumenis Be, Ltd., a global leader in developing and commercializing energy-based solutions for the Aesthetic and Vision markets, is proud to announce that the Facial Muscle Stimulation treatment that has taken over the U.S. is now coming to Canada. triLift, the groundbreaking Dynamic Muscle Stimulation technology (DMSt™), has received a Medical Device License (MDL) from Health Canada.

Finally, practitioners in Canada can go beyond the skin, to address a key cause of facial aging—the muscles. With triLift, addressing the facial muscles is possible without invasive surgical methods.
Finally, practitioners in Canada can go beyond the skin, to address a key cause of facial aging—the muscles. With triLift, addressing the facial muscles is possible without invasive surgical methods.

Our muscles play a crucial role in defining facial structure, and as we age, we lose facial muscle mass, leading to sagging jawlines, droopy cheekbones, the appearance of mouth folds and baggy lower eyelids. triLift is a game-changing advancement in the facial aesthetics market with its novel Dynamic Muscle Stimulation (DMSt™) technology complemented by RF and RF microneedling. By specifically targeting the facial muscles, triLift effectively treats structure, contour, and texture, resulting in a naturally lifted look, reduced wrinkles and a tighter, smoother jawline. It also allows for each patient to receive targeted and customized treatments.

Finally, practitioners in Canada can go beyond the skin, to address a key cause of facial aging—the muscles. With triLift, addressing the facial muscles is possible without invasive surgical methods. triLift's Dynamic Muscle Stimulation technology (DMSt™) activates and tones facial muscles by stimulating muscle contractions that mimic physiological muscle function, but at a high frequency and intensity. This dynamic approach results in visible and natural-looking results from the first treatment.1

"This is an exciting moment and ultimate game changer for those who are seeking a non-invasive way to address the facial muscle," stated Dr. James Chelnis of Manhattan Face and Eye. "For patients who want to avoid injectables and surgery, triLift's facial muscle stimulation technology is a major breakthrough for the Canadian market. triLift by Lumenis is a unique device, allowing providers to target a patient's specific need with a quick, comfortable treatment option. Patients will love that the results are visible and noticeable".4

triLift also targets the epidermal and dermal layers through the sequential use of two synergistic technologies with DMSt:

  • TriPollar® RF employs third-generation technology, reaching significant depths, with a high safety profile - ideal for the face. Regenerating collagen,2 increasing dermal thickness by 50%2, and reducing wrinkles by 30%3.
  • triFX™ Radiofrequency Microneedling, with its ultrathin needles, increases smoothness by 80%3, and triples hyaluronic acid production3. This combination offers significant results without downtime or numbing.

Patients and physicians across Canada now have a safe, approachable, non-invasive, 20-30 minute in-office treatment option that is designed to specifically address the facial muscles and deliver a face lift-like effect. Celebrities such as Alyssa Milano, Jennie Garth, Colton Underwood, Kerri Walsh, Teddi Mellencamp, and Teresa Guidice, all expressed their enthusiasm regarding their resulted natural lifted look.4

The official Canada launch event will take place on March 28, 2024, in Toronto. This is another important milestone for Lumenis as triLift continues its global expansion as an exciting new option for facial muscle stimulation, and addressing facial muscles, skin and volume, all in one treatment.

Lumenis, the inventors of gold standard Aesthetics technologies such as Intense Pulsed Light (IPL), CO2 and fractional lasers, disrupted the aesthetic industry once again with the innovative facial muscle stimulation device, triLift. triLift's multilayer approach allows muscle, skin, and volume to be reached in one treatment, through its Dynamic Muscle Stimulation (DMSTTM) technology. triLift is safe for all skin types and tones, can be complementary alongside other aesthetic treatments, is easy to perform, making it a great addition to any practice or medical spa.

"The clearance of triLift by Health Canada is a significant moment in the Canadian facial aesthetics market," said Lumenis Vice President & Regional President, Americas, Brad Oliver. "triLift facial muscle stimulation allows patients to finally address a key root cause of facial aging, muscle atrophy. Patients can now regain their youthful and toned appearance through a natural, non-invasive, energy-based solution. Lumenis looks forward to partnering with Canadian providers to bring their practices this groundbreaking treatment and provide patients with a new and natural way to address facial aging without surgery".

For more information regarding the March 28 launch event in Toronto, click here. To stay up to date on all things triLift, follow Lumenis on Instagram at @lumenis.aesthetics.

1 The recommended treatment protocol is 5 treatments, 1 week apart for optimal results.

2 Haim Kaplan, Andrea Gat, Clinical and histopathological results following TriPollar™ radiofrequency skin treatments Journal of Cosmetic and Laser Therapy 2009; 11: 78–84 DOI: 10.1080/14764170902846227

3 Potekaev N, Zhukova O. Evaluation of Safety and efficacy of the Maximus System for facial wrinkles. Journal of Cosmetics, Dermatological Sciences and Applications, 2013; Vol. 3: 151-156.

4 This testimonial represents a specific experience of a paid spokesperson. Experience of others may vary

About Lumenis
Lumenis is a global leader in the medical aesthetic market and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radiofrequency (RF). Excelling a new category in facial aesthetics, Lumenis is evolving the beauty market through patient focused products that treat and solve providers' biggest problems. Lumenis is the leader in minimally invasive facial aesthetics products, and with a portfolio of globally renowned products that range from skin care to body treatments. 

For more than 50 years, Lumenis' ground-breaking products have redefined medical treatments and set technological and clinical gold-standards, revolutionizing existing treatment methods, and creating solutions for previously untreatable conditions. Lumenis is a portfolio company of Baring Private Equity Asia.

For more information regarding Lumenis' range of clinical solutions, please visit: https://trilift.me/

About triLift

Lumenis energy-based treatments are not suitable for everyone and do carry some risks. triLift treatment is not suitable for patients with pacemakers, defibrillators, or any implanted electronic devices, as well as metal implants in the treatment area. Risks may include damage to natural skin texture, skin redness, swelling, bruising, itching and change of pigmentation. Be sure to consult with your treatment provider before choosing this treatment.

Photo: https://mma.prnewswire.com/media/2370625/triLift_Lumenis.jpg

Contact:
Gabby White
+1-219-775-6717
[email protected] 

Chen Reingold
+972 548-133-777
[email protected] 

SOURCE Lumenis Be Ltd.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.